The future of prostate care just got a $31.5M boost, as MaxQ Medical announced the close of its Series A funding round. The company is developing a next-generation ultrasound system that combines advanced electronics and signal processing to deliver a transformative imaging and therapy solution.
MaxQ Medical's innovation centers on the world鈥檚 first fully automated, urethra-preserving, outpatient ultrasound imaging and targeted HIFU (High-Intensity Focused Ultrasound) therapy system. This technology aims to empower urologists to deliver fully customized treatment plans tailored to each patient鈥檚 anatomy, promising optimal outcomes with minimal side-effects.








.png&w=3840&q=75)








